JP2008534555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008534555A5 JP2008534555A5 JP2008503513A JP2008503513A JP2008534555A5 JP 2008534555 A5 JP2008534555 A5 JP 2008534555A5 JP 2008503513 A JP2008503513 A JP 2008503513A JP 2008503513 A JP2008503513 A JP 2008503513A JP 2008534555 A5 JP2008534555 A5 JP 2008534555A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- alkoxy
- halogen
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 48
- 229910052736 halogen Inorganic materials 0.000 claims 34
- 150000002367 halogens Chemical group 0.000 claims 34
- 229910052739 hydrogen Inorganic materials 0.000 claims 27
- 239000001257 hydrogen Substances 0.000 claims 27
- 150000002431 hydrogen Chemical group 0.000 claims 24
- -1 phenylsulfonylamino, phenyl Chemical group 0.000 claims 24
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 19
- 229910052757 nitrogen Inorganic materials 0.000 claims 18
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 16
- 101100177165 Caenorhabditis elegans har-1 gene Proteins 0.000 claims 15
- 229910052799 carbon Inorganic materials 0.000 claims 13
- 125000004432 carbon atom Chemical group C* 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- 125000004076 pyridyl group Chemical group 0.000 claims 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 12
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 11
- 125000002950 monocyclic group Chemical group 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 229910052717 sulfur Chemical group 0.000 claims 8
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 7
- 239000005977 Ethylene Substances 0.000 claims 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 6
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 6
- 125000002541 furyl group Chemical group 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 239000001301 oxygen Chemical group 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 239000011593 sulfur Chemical group 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 5
- 239000011737 fluorine Substances 0.000 claims 5
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- 125000001544 thienyl group Chemical group 0.000 claims 5
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 claims 4
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 claims 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 4
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000002393 azetidinyl group Chemical group 0.000 claims 3
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 125000004193 piperazinyl group Chemical group 0.000 claims 3
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 2
- 125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 2
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 claims 2
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 208000037976 chronic inflammation Diseases 0.000 claims 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 2
- HKSQBYDNTRZFIB-UHFFFAOYSA-N 2-[2-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)ethyl]-3,4,5,6-tetrahydro-2h-azepin-7-amine Chemical compound C1CCCC(N)=NC1CCC1=NC2=CC(C=3C=CC=CC=3)=CN=C2N1 HKSQBYDNTRZFIB-UHFFFAOYSA-N 0.000 claims 1
- WXLDGVNDECPCBJ-UHFFFAOYSA-N 2-[2-[6-(4-methoxyphenyl)-1h-imidazo[4,5-b]pyridin-2-yl]ethyl]-3,4,5,6-tetrahydro-2h-azepin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=CN=C(NC(CCC2N=C(N)CCCC2)=N2)C2=C1 WXLDGVNDECPCBJ-UHFFFAOYSA-N 0.000 claims 1
- DRYZQRZFAPCMTK-UHFFFAOYSA-N 2-[2-[6-[4-(4-ethylpiperazin-1-yl)sulfonylphenyl]-1h-imidazo[4,5-b]pyridin-2-yl]ethyl]-3,4,5,6-tetrahydro-2h-azepin-7-amine Chemical compound C1CN(CC)CCN1S(=O)(=O)C1=CC=C(C=2C=C3N=C(CCC4N=C(N)CCCC4)NC3=NC=2)C=C1 DRYZQRZFAPCMTK-UHFFFAOYSA-N 0.000 claims 1
- ASMBHBZLTUPKPV-UHFFFAOYSA-N 2-[2-[6-[4-(azetidin-1-ylsulfonyl)phenyl]-1h-imidazo[4,5-b]pyridin-2-yl]ethyl]-3,4,5,6-tetrahydro-2h-azepin-7-amine Chemical compound C1CCCC(N)=NC1CCC1=NC2=CC(C=3C=CC(=CC=3)S(=O)(=O)N3CCC3)=CN=C2N1 ASMBHBZLTUPKPV-UHFFFAOYSA-N 0.000 claims 1
- LORSIJSDDJMADF-UHFFFAOYSA-N 4-[2-[2-(7-amino-3,4,5,6-tetrahydro-2h-azepin-2-yl)ethyl]-1h-imidazo[4,5-b]pyridin-6-yl]-n,n-dimethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1C1=CN=C(NC(CCC2N=C(N)CCCC2)=N2)C2=C1 LORSIJSDDJMADF-UHFFFAOYSA-N 0.000 claims 1
- UITKJVPMFSOFQV-UHFFFAOYSA-N 4-[2-[2-(7-amino-3,4,5,6-tetrahydro-2h-azepin-2-yl)ethyl]-1h-imidazo[4,5-b]pyridin-6-yl]-n-(2-methylphenyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1NS(=O)(=O)C1=CC=C(C=2C=C3N=C(CCC4N=C(N)CCCC4)NC3=NC=2)C=C1 UITKJVPMFSOFQV-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004980 cyclopropylene group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002366 halogen compounds Chemical class 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102558 | 2005-03-31 | ||
| PCT/EP2006/061141 WO2006103255A1 (en) | 2005-03-31 | 2006-03-29 | Imidazopyridine derivatives useful as inos inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008534555A JP2008534555A (ja) | 2008-08-28 |
| JP2008534555A5 true JP2008534555A5 (enExample) | 2009-05-14 |
Family
ID=35448230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503513A Withdrawn JP2008534555A (ja) | 2005-03-31 | 2006-03-29 | ｉＮＯＳインヒビターとして有用なイミダゾピリジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7790710B2 (enExample) |
| EP (1) | EP1866306B1 (enExample) |
| JP (1) | JP2008534555A (enExample) |
| AT (1) | ATE433975T1 (enExample) |
| AU (1) | AU2006228142A1 (enExample) |
| CA (1) | CA2602284A1 (enExample) |
| DE (1) | DE602006007326D1 (enExample) |
| ES (1) | ES2328626T3 (enExample) |
| WO (1) | WO2006103255A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008086176A2 (en) * | 2007-01-08 | 2008-07-17 | Kalypsys, Inc. | Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| TW200924772A (en) * | 2007-08-27 | 2009-06-16 | Kalypsys Inc | Heterobicyclic-substituted quinolones useful as nitric oxide synthase inhibitors |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| ES2206571T3 (es) | 1995-04-20 | 2004-05-16 | G.D. SEARLE & CO. | Agentes de amidino ciclico utiles como inhibidores de la oxido nitrico sintasa. |
| JP2004512271A (ja) | 2000-08-01 | 2004-04-22 | ファルマシア・コーポレーション | 誘導型一酸化窒素シンターゼ阻害薬としてのヘキサヒドロ−７−１ｈ−アゼピン−２−イル−ヘキサン酸誘導体 |
| BR0308785A (pt) * | 2002-03-27 | 2005-01-11 | Altana Pharma Ag | Derivados de alcoxipiridina |
| KR20050107433A (ko) | 2003-02-25 | 2005-11-11 | 알타나 파마 아게 | 이미다조[4,5-ｂ]퀴놀린 유도체 및 ｎｏ-신타제억제제로서의 이의 용도 |
| EP1670798A1 (en) | 2003-10-01 | 2006-06-21 | Altana Pharma AG | Aminopyridine-derivatives as inductible no-synthase inhibitors |
-
2006
- 2006-03-29 EP EP06725397A patent/EP1866306B1/en not_active Expired - Lifetime
- 2006-03-29 CA CA002602284A patent/CA2602284A1/en not_active Abandoned
- 2006-03-29 AU AU2006228142A patent/AU2006228142A1/en not_active Abandoned
- 2006-03-29 AT AT06725397T patent/ATE433975T1/de not_active IP Right Cessation
- 2006-03-29 WO PCT/EP2006/061141 patent/WO2006103255A1/en not_active Ceased
- 2006-03-29 JP JP2008503513A patent/JP2008534555A/ja not_active Withdrawn
- 2006-03-29 DE DE602006007326T patent/DE602006007326D1/de not_active Expired - Lifetime
- 2006-03-29 US US11/886,785 patent/US7790710B2/en not_active Expired - Fee Related
- 2006-03-29 ES ES06725397T patent/ES2328626T3/es not_active Expired - Lifetime
-
2010
- 2010-08-03 US US12/849,571 patent/US20100317650A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520885A5 (enExample) | ||
| CA2829131C (en) | Amino-quinolines as kinase inhibitors | |
| JP5864589B2 (ja) | 細菌トポイソメラーゼｉｉ阻害性２−エチルカルバモイルアミノ−１，３−ベンゾチアゾール−５−イル類 | |
| IL156751A (en) | Transformed alkylamines and pharmaceutical preparations that include them | |
| RU2010134900A (ru) | 5-фторпиримидиновые производные в качестве фунгицидов | |
| JP2011527677A5 (enExample) | ||
| JP2010524970A5 (enExample) | ||
| JP6067181B2 (ja) | アルドステロンシンターゼ阻害薬 | |
| RU2019123031A (ru) | (аза)индол-, бензотиофен- и бензофуран-3-сульфонамиды | |
| AU2003252011A1 (en) | Substituted 2-alkylamine nicotinic amide derivatives and use there of | |
| JP2011515371A (ja) | 新規ヘテロ環式化合物およびそれらの使用 | |
| CN106749231B (zh) | 萘啶化合物和药物组合物及它们的应用 | |
| JP2012512888A5 (enExample) | ||
| EP2909193A1 (en) | Phenyl linked quinolinyl modulators of ror-gamma-t | |
| AU2015236438A1 (en) | TrkA kinase inhibitors, compositions and methods thereof | |
| AU2003256577A1 (en) | Substituted benzylamine derivatives and methods of use | |
| EP3843842A1 (en) | Cardiac sarcomere inhibitors | |
| KR20150143479A (ko) | Ｆａｓｎ 억제용 신규 화합물 및 조성물 | |
| JP2013510178A5 (enExample) | ||
| EP4055013A1 (en) | Wdr5 inhibitors and modulators | |
| CN110114358A (zh) | 新的化合物以及其药理学上所容许的盐 | |
| KR102390234B1 (ko) | 트리시클릭 피페리딘 화합물 | |
| KR20190077327A (ko) | 피리도 5원 방향족 고리계 화합물, 이의 제조 방법 및 용도 | |
| JP2019524732A5 (enExample) | ||
| ES3060367T3 (en) | New imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |